Peptide Comparison
5-Amino-1MQvsTirzepatide
A small-molecule NNMT inhibitor studied in animals for fat loss and NAD+ metabolism.
The dual-action powerhouse that targets both GIP and GLP-1 receptors, delivering the most dramatic weight loss results ever seen in a medication—averaging over 20% body weight reduction while also crushing blood sugar levels in people with diabetes.
At a Glance
Quick
comparison
Dose Range
5-Amino-1MQ
50–150 mg
Tirzepatide
2.5–15 mg
Frequency
5-Amino-1MQ
Once daily
Tirzepatide
Once weekly
Administration
5-Amino-1MQ
Subcutaneous injection
Tirzepatide
Subcutaneous injection
Cycle Length
5-Amino-1MQ
8-12 weeks (community-reported; no human trial data)
Tirzepatide
Ongoing/indefinite
Onset Speed
5-Amino-1MQ
Not established in humans; gradual over weeks in animal studies
Tirzepatide
Moderate (1-2 weeks)
Evidence Level
5-Amino-1MQ
Preclinical only (animal and lab studies; no human trials)
Tirzepatide
Strong human trials (Phase 3 or FDA approved)
Efficacy
Benefit
ratings
Fat and weight reduction
Metabolic markers
NAD+ / cellular energy
Human evidence
Weight Loss
Appetite Control
Blood Sugar Control
Technical Data
Compound
specifications
5-Amino-1MQ
Molecular Formula
C10H11N2+ (cation); commonly supplied as the iodide salt (C10H11IN2)
Molecular Weight
159.21 g/mol (cation); 286.11 g/mol (iodide salt)
Half-Life
Not established in humans; preclinical rodent data suggest a few hours (compound is membrane-permeable and orally active)
Bioavailability
Orally bioavailable in animal studies (high membrane permeability shown by PAMPA and Caco-2 assays); human data not established
CAS Number
42464-96-0 (salt form)
Tirzepatide
Molecular Formula
C225H348N48O68
Molecular Weight
4813.45 g/mol
Half-Life
Approximately 5 days (120 hours)
Bioavailability
~80% (subcutaneous)
CAS Number
2023788-19-2
Protocols
Dosing
tiers
5-Amino-1MQ
Tirzepatide
Applications
Best
suited for
5-Amino-1MQ
Fat loss research
The clearest, most repeated finding: obese mice lost body weight and fat mass on 5-Amino-1MQ without eating less [1][2]. This is the main reason people are interested — though it is animal data, not human proof.
Metabolic health support
In mice, it improved blood sugar, insulin, and liver fat [2]. Researchers see NNMT inhibition as a promising angle for metabolic syndrome [4].
NAD+ and cellular energy science
By blocking NNMT, it raises NAD+ and SAM inside cells, which supports how cells make and use energy [1][4]. This makes it interesting to people studying aging and metabolism.
Tirzepatide
People Who Want Maximum Weight Loss Results
If you're serious about losing significant weight, tirzepatide delivers results that were previously only achievable through bariatric surgery. Clinical trials showed average weight loss exceeding 20% of body weight—that's 50+ pounds for someone starting at 250 pounds. No other medication comes close.
Those Who Haven't Succeeded with Semaglutide
Thanks to its dual GIP/GLP-1 mechanism, tirzepatide often works better for people who had limited results with GLP-1-only drugs like semaglutide. The added GIP activation provides extra metabolic benefits that can break through plateaus and deliver superior weight loss.
People with Type 2 Diabetes Needing Aggressive Control
Head-to-head trials proved tirzepatide beats semaglutide for blood sugar control. The average HbA1c reduction of over 2 percentage points means many people can dramatically reduce or eliminate other diabetes medications. It's a genuine game-changer for metabolic health.
Individuals Looking to Transform Their Relationship with Food
Tirzepatide doesn't just reduce hunger—it fundamentally changes how food appeals to you. Users describe feeling free from constant food thoughts, finding it easy to stop eating when satisfied, and losing interest in formerly irresistible treats. It's not willpower—it's biochemistry working for you.
Safety Profile
Side
effects
5-Amino-1MQ
Common
- No verified human side effects
- Mild nausea or headache (community-reported)
Uncommon
- Fatigue or flushing (community-reported)
Serious
- Possible off-target MAO-A effects (theoretical)
- Unknown long-term and human risks
Tirzepatide
Common
- Nausea
- Diarrhea
- Decreased Appetite
- Vomiting
Uncommon
- Gallbladder Problems
- Hair Thinning (Telogen Effluvium)
Serious
- Pancreatitis
- Thyroid Tumors (Theoretical Risk)
Research Status
Safety
& evidence
5-Amino-1MQ
Evidence Level
Preclinical only (animal and lab studies; no human trials)
FDA Status
Research compound — not FDA approved
Safety Overview
Here is the honest picture: no one has run a human safety trial on 5-Amino-1MQ. Everything we know about safety comes from mice. In those studies, the animals tolerated it well — no obvious harm, no change in appetite, and healthier livers at the doses tested [1][2]. But mice are not people, and short animal studies cannot rule out problems that show up over months or years in humans. Treat this as an experimental compound. If you are considering it, talk to a doctor first, especially if you take any medication.
Contraindications
- xNo human safety data exists — all evidence is from animals and lab work
- xPregnancy or breastfeeding
- xUse with MAO-A-sensitive medications, given off-target MAO-A inhibition seen in lab screening [2]
Tirzepatide
Evidence Level
Strong human trials (Phase 3 or FDA approved)
FDA Status
FDA approved for this use
Safety Overview
Tirzepatide has been extensively studied in the SURPASS (diabetes) and SURMOUNT (obesity) trial programs, involving thousands of participants over multiple years. The FDA approved it after thorough safety review. While GI side effects are common (especially during dose increases), they're typically mild to moderate and improve over time. Serious adverse events are rare. The SURPASS-CVOT trial is ongoing to evaluate long-term cardiovascular outcomes.
Contraindications
- xPersonal or family history of medullary thyroid carcinoma (MTC)
- xMultiple Endocrine Neoplasia syndrome type 2 (MEN2)
- xHistory of serious allergic reaction to tirzepatide or any GLP-1/GIP medication
- xCurrent or recent pancreatitis
- xPregnancy or planning to become pregnant
Decision Guide
Which is
right for you?
Choose 5-Amino-1MQ if...
- Fat loss (research context)
- Metabolic health support
- NAD+ and cellular energy metabolism
Choose Tirzepatide if...
- Maximum weight loss results
- Long-term obesity management
- Type 2 diabetes control
- Metabolic health improvement